×
ADVERTISEMENT

MARCH 17, 2022

How Will Mark Cuban's Cost Plus Drug Co. Disrupt the Pharmacy Ecosystem?

By Gina Shaw

Generic imatinib (Gleevec, Novartis) for $17.10 per month, compared with $2,502.80 at retail? Generic memantine (Namenda XR, Allergan) for $12.90 per month, compared with $359.42 at retail? Generic esomeprazole (Nexium, Pfizer) for just $6, compared with $216.66?

These are just a few of the 27 drugs that will be discounted by $100 or more per prescription—sometimes a lot more—from billionaire Mark Cuban’s generic drug company, Mark Cuban Cost Plus Drug Co. (MCCPDC),